uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
18.05
+0.15 (0.84%)
Apr 28, 2026, 4:00 PM EDT - Market closed
uniQure Market Cap
uniQure has a market cap or net worth of $1.14 billion as of April 29, 2026. Its market cap has increased by 145.52% in one year.
Market Cap
1.14B
Enterprise Value
1.05B
1-Year Change
145.52%
Ranking
Category
Stock Price
$18.05
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $1.14B, an increase of 606.24%. That is a compound annual growth rate of 23.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.12B | -24.91% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 1.22B |
| MoonLake Immunotherapeutics | 1.21B |
| Pharming Group | 1.18B |
| UroGen Pharma | 1.16B |
| EyePoint | 1.13B |
| Septerna | 1.13B |
| Aktis Oncology | 1.11B |
| Zenas BioPharma | 1.11B |